DE60231246D1 - Superoxiddismutas-mimetika zur behandlung von augenerkrankungen - Google Patents

Superoxiddismutas-mimetika zur behandlung von augenerkrankungen

Info

Publication number
DE60231246D1
DE60231246D1 DE60231246T DE60231246T DE60231246D1 DE 60231246 D1 DE60231246 D1 DE 60231246D1 DE 60231246 T DE60231246 T DE 60231246T DE 60231246 T DE60231246 T DE 60231246T DE 60231246 D1 DE60231246 D1 DE 60231246D1
Authority
DE
Germany
Prior art keywords
treatment
distutas
mimetics
superoxide
eye diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231246T
Other languages
English (en)
Inventor
Robert J Collier
Mark R Hellberg
Peter G Klimko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DE60231246D1 publication Critical patent/DE60231246D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE60231246T 2001-12-14 2002-12-06 Superoxiddismutas-mimetika zur behandlung von augenerkrankungen Expired - Lifetime DE60231246D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34038901P 2001-12-14 2001-12-14
PCT/US2002/039037 WO2003051458A1 (en) 2001-12-14 2002-12-06 Superoxide dismutase mimics for the treatment of ocular disorders and diseases

Publications (1)

Publication Number Publication Date
DE60231246D1 true DE60231246D1 (de) 2009-04-02

Family

ID=23333158

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231246T Expired - Lifetime DE60231246D1 (de) 2001-12-14 2002-12-06 Superoxiddismutas-mimetika zur behandlung von augenerkrankungen

Country Status (19)

Country Link
US (2) US7759333B2 (de)
EP (1) EP1463563B1 (de)
JP (1) JP2005513063A (de)
KR (1) KR100951606B1 (de)
CN (2) CN1620325A (de)
AT (1) ATE422944T1 (de)
BR (1) BR0214957A (de)
CA (1) CA2470721C (de)
CY (1) CY1108983T1 (de)
DE (1) DE60231246D1 (de)
DK (1) DK1463563T3 (de)
ES (1) ES2319399T3 (de)
HK (1) HK1069785A1 (de)
MX (1) MXPA04005601A (de)
PL (1) PL210225B1 (de)
PT (1) PT1463563E (de)
SI (1) SI1463563T1 (de)
WO (1) WO2003051458A1 (de)
ZA (1) ZA200404435B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1463563T3 (da) * 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme
EP1691815A4 (de) * 2003-12-11 2010-03-31 Alcon Inc Superoxid-dismutase-mimetika zur behandlung von optikus- und retinaschäden
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
CA2747161C (en) 2008-12-19 2017-07-18 Abbott Laboratories (hetero)aryl substituted (benzo[d]thiazol-2-ylcarbamoyl) 1,2,3,4-tetrahydroquinolins and related compounds and uses thereof for treating cancer and excess platelets
EP2433640B1 (de) 2010-09-24 2020-01-15 OmniVision GmbH Zusammensetzung mit SOD, Lutein und Zeaxanthin
KR101214364B1 (ko) * 2011-02-15 2012-12-21 한림대학교 산학협력단 수퍼옥사이드 디스뮤테이즈 융합 단백질을 함유하는 안과 질환 예방 또는 치료용 약제학적 조성물
JP6267638B2 (ja) * 2011-09-26 2018-01-24 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーＧａｌｅｒａ Ｌａｂｓ， Ｌｌｃ 疾患の治療方法
WO2023120828A1 (ko) * 2021-12-23 2023-06-29 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 건성 황반변성의 예방 또는 치료용 용도
WO2023224136A1 (ko) * 2022-05-16 2023-11-23 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 당뇨망막병증 또는 포도막염의 예방 또는 치료용 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
SE9402816D0 (sv) 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
EP1045851B1 (de) 1997-11-03 2003-04-23 Duke University Substituierte porphyrinen
WO2000007584A2 (en) 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
GB9817845D0 (en) * 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
EP1185312B1 (de) 1999-05-27 2005-03-23 Monsanto Company Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
DK1463563T3 (da) 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme

Also Published As

Publication number Publication date
PT1463563E (pt) 2009-03-19
CY1108983T1 (el) 2014-07-02
HK1069785A1 (en) 2005-06-03
US7759333B2 (en) 2010-07-20
WO2003051458A1 (en) 2003-06-26
MXPA04005601A (es) 2004-12-06
AU2002351267A1 (en) 2003-06-30
SI1463563T1 (sl) 2009-06-30
ZA200404435B (en) 2006-05-31
KR20040063943A (ko) 2004-07-14
US20100204194A1 (en) 2010-08-12
CN1620325A (zh) 2005-05-25
EP1463563A1 (de) 2004-10-06
PL369607A1 (en) 2005-05-02
US8003635B2 (en) 2011-08-23
ES2319399T3 (es) 2009-05-07
CA2470721A1 (en) 2003-06-26
ATE422944T1 (de) 2009-03-15
DK1463563T3 (da) 2009-04-20
CA2470721C (en) 2011-07-12
JP2005513063A (ja) 2005-05-12
BR0214957A (pt) 2004-12-14
CN101092432A (zh) 2007-12-26
AU2002351267B2 (en) 2007-04-05
EP1463563B1 (de) 2009-02-18
US20050032768A1 (en) 2005-02-10
PL210225B1 (pl) 2011-12-30
KR100951606B1 (ko) 2010-04-09

Similar Documents

Publication Publication Date Title
CY1108983T1 (el) Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων
BR0317026A (pt) Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares
DE60101265D1 (de) Behandlung von augenschmerzen
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60019473D1 (de) (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
ATE383874T1 (de) Perylenequinonen zur anwendung als sonosensitizer
ATE258793T1 (de) 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom
ATE487482T1 (de) Superoxid-dismutase-mimika zur behandlungvon augenstörungen und erkrankungen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE253936T1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids
ATE541566T1 (de) Zusammensetzungen zur behandlung von erkrankungen der augenoberfläche
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
BRPI0417549A (pt) miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal
ATE344054T1 (de) Behandlung von okularen neovaskularen erkrankungen
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition